Loading...
Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor‐induced renal immune‐related adverse events
Immune checkpoint inhibitors (ICIs) are nowadays widely used in clinical oncology treatment, and significantly improve the prognosis of cancer patients. However, overactivation of T cells and related signaling pathways caused by ICIs can also induce immune‐related adverse effects (irAEs). Renal immu...
Na minha lista:
| Udgivet i: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons Australia, Ltd
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7262914/ https://ncbi.nlm.nih.gov/pubmed/32232975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13405 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|